Biotech sector sees increased funding for Q1

04/5/2012 | BioWorld Online (free registration)

For the first three months of the year, U.S. biotech venture funding rounds reached $391 million, a 34% increase to figures for the same period last year, according to BioWorld data. The biggest increases came in support of early-stage innovations: Series A and seed deals brought in 63% more funding in the first quarter. The trend suggests the biotech industry could be a healthier environment for investing in 2012.

View Full Article in:

BioWorld Online (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA